Cost of treatment support for multidrug-resistant tuberculosis using patient-centred approaches in Ethiopia: a model-based method
Patient and health system costs for treating multidrug-resistant tuberculosis (MDR-TB) remain high even after treatment duration was shortened. Many patients do not finish treatment, contributing to increased ...
![](https://static-content.springer.com/image/art%3A10.1186%2Fs40249-023-01116-w/MediaObjects/40249_2023_1116_Figa_HTML.png)